IL183983A0 - Processes for producing 4-aminoquinazoline derivatives - Google Patents

Processes for producing 4-aminoquinazoline derivatives

Info

Publication number
IL183983A0
IL183983A0 IL183983A IL18398307A IL183983A0 IL 183983 A0 IL183983 A0 IL 183983A0 IL 183983 A IL183983 A IL 183983A IL 18398307 A IL18398307 A IL 18398307A IL 183983 A0 IL183983 A0 IL 183983A0
Authority
IL
Israel
Prior art keywords
processes
producing
aminoquinazoline derivatives
aminoquinazoline
derivatives
Prior art date
Application number
IL183983A
Other versions
IL183983A (en
Original Assignee
Vertex Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vertex Pharma filed Critical Vertex Pharma
Publication of IL183983A0 publication Critical patent/IL183983A0/en
Publication of IL183983A publication Critical patent/IL183983A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/24—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/40—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
    • C07C271/58—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C07D239/91—Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/94—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL183983A 2004-12-17 2007-06-17 Processes for producing 4-aminoquinazoline derivatives IL183983A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63727804P 2004-12-17 2004-12-17
PCT/US2005/045506 WO2006066044A2 (en) 2004-12-17 2005-12-15 Processes for producing 4-aminoquinazolines

Publications (2)

Publication Number Publication Date
IL183983A0 true IL183983A0 (en) 2007-10-31
IL183983A IL183983A (en) 2012-04-30

Family

ID=36588571

Family Applications (1)

Application Number Title Priority Date Filing Date
IL183983A IL183983A (en) 2004-12-17 2007-06-17 Processes for producing 4-aminoquinazoline derivatives

Country Status (18)

Country Link
US (1) US20060166963A1 (en)
EP (2) EP1828150B1 (en)
JP (2) JP5030787B2 (en)
KR (1) KR20070091660A (en)
CN (1) CN101111487A (en)
AR (1) AR053317A1 (en)
AT (1) ATE549314T1 (en)
AU (1) AU2005316454B2 (en)
BR (1) BRPI0519600A2 (en)
CA (1) CA2591588A1 (en)
ES (1) ES2382200T3 (en)
IL (1) IL183983A (en)
MX (1) MX2007007446A (en)
PL (1) PL382927A1 (en)
RU (1) RU2007127315A (en)
TW (1) TW200635905A (en)
WO (1) WO2006066044A2 (en)
ZA (1) ZA200704972B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7713983B2 (en) * 2003-03-03 2010-05-11 Vertex Pharmaceuticals Incorporated Quinazolines useful as modulators of ion channels
CL2004000409A1 (en) * 2003-03-03 2005-01-07 Vertex Pharma COMPOUNDS DERIVED FROM 2- (REPLACED CILO) -1- (AMINO OR REPLACED OXI) -CHINAZOLINE, INHIBITORS OF IONIC SODIUM AND CALCIUM VOLTAGE DEPENDENTS; PHARMACEUTICAL COMPOSITION; AND USE OF THE COMPOUND IN THE TREATMENT OF ACUTE PAIN, CHRONIC, NEU
US7718658B2 (en) * 2004-09-02 2010-05-18 Vertex Pharmaceuticals Incorporated Quinazolines useful as modulators of ion channels
US7928107B2 (en) * 2004-09-02 2011-04-19 Vertex Pharmaceuticals Incorporated Quinazolines useful as modulators of ion channels
US8283354B2 (en) * 2004-09-02 2012-10-09 Vertex Pharmaceuticals Incorporated Quinazolines useful as modulators of ion channels
US8158637B2 (en) * 2005-11-14 2012-04-17 Vertex Pharmaceuticals Incorporated Quinazolines useful as modulators of voltage gated ion channels
EP1968968A1 (en) * 2005-12-21 2008-09-17 PainCeptor Pharma Corp. Compositions and methods for modulating gated ion channels
WO2008069976A2 (en) * 2006-12-01 2008-06-12 President And Fellows Of Harvard College Compounds and methods for enzyme-mediated tumor imaging and therapy
CN102318191B (en) * 2009-08-31 2014-02-26 欧姆龙株式会社 Multiple optical axis photoelectric sensor
CN106632088B (en) * 2015-10-30 2019-04-19 华南理工大学 A kind of aggregation-induced emission probe and its preparation method and application based on quianzolinones

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3637693A (en) * 1968-07-12 1972-01-25 Du Pont Hydroxyarylquinazolines and their use as uv-absorbers
US3819628A (en) * 1972-07-31 1974-06-25 Sandoz Ag 2-phenyl-4-substituted amino-quinazolines and nitrates thereof
DE19756388A1 (en) * 1997-12-18 1999-06-24 Hoechst Marion Roussel De Gmbh New 2-aryl-4-amino-6,7-di:methoxy-quinazoline derivatives useful as guanylate cyclase activators for treating cardiovascular diseases, etc.
US6184226B1 (en) * 1998-08-28 2001-02-06 Scios Inc. Quinazoline derivatives as inhibitors of P-38 α
US6608053B2 (en) * 2000-04-27 2003-08-19 Yamanouchi Pharmaceutical Co., Ltd. Fused heteroaryl derivatives
US6813772B2 (en) * 2000-09-29 2004-11-02 Matsushita Electric Industrial Co., Ltd. Optical disk drive
US7713983B2 (en) * 2003-03-03 2010-05-11 Vertex Pharmaceuticals Incorporated Quinazolines useful as modulators of ion channels
CL2004000409A1 (en) * 2003-03-03 2005-01-07 Vertex Pharma COMPOUNDS DERIVED FROM 2- (REPLACED CILO) -1- (AMINO OR REPLACED OXI) -CHINAZOLINE, INHIBITORS OF IONIC SODIUM AND CALCIUM VOLTAGE DEPENDENTS; PHARMACEUTICAL COMPOSITION; AND USE OF THE COMPOUND IN THE TREATMENT OF ACUTE PAIN, CHRONIC, NEU
ATE398125T1 (en) * 2003-03-12 2008-07-15 Millennium Pharm Inc QUINAZOLINE DERIVATIVES AS TGF BETA INHIBITORS
US7718658B2 (en) * 2004-09-02 2010-05-18 Vertex Pharmaceuticals Incorporated Quinazolines useful as modulators of ion channels
US8283354B2 (en) * 2004-09-02 2012-10-09 Vertex Pharmaceuticals Incorporated Quinazolines useful as modulators of ion channels
US8158637B2 (en) * 2005-11-14 2012-04-17 Vertex Pharmaceuticals Incorporated Quinazolines useful as modulators of voltage gated ion channels

Also Published As

Publication number Publication date
CN101111487A (en) 2008-01-23
ES2382200T3 (en) 2012-06-06
PL382927A1 (en) 2008-02-04
KR20070091660A (en) 2007-09-11
IL183983A (en) 2012-04-30
JP2012056968A (en) 2012-03-22
WO2006066044A2 (en) 2006-06-22
CA2591588A1 (en) 2006-06-22
WO2006066044A3 (en) 2007-05-10
BRPI0519600A2 (en) 2009-02-25
RU2007127315A (en) 2009-01-27
EP2366696A1 (en) 2011-09-21
US20060166963A1 (en) 2006-07-27
AR053317A1 (en) 2007-05-02
ATE549314T1 (en) 2012-03-15
JP2008524238A (en) 2008-07-10
EP1828150B1 (en) 2012-03-14
EP1828150A2 (en) 2007-09-05
TW200635905A (en) 2006-10-16
JP5030787B2 (en) 2012-09-19
MX2007007446A (en) 2008-01-14
ZA200704972B (en) 2008-09-25
AU2005316454A1 (en) 2006-06-22
AU2005316454B2 (en) 2012-09-06

Similar Documents

Publication Publication Date Title
IL178233A0 (en) Process for producing 5-hydroxy-4-thiomethylpyrazole derivatives
GB0416001D0 (en) Process
GB0407329D0 (en) Process
GB0418654D0 (en) Process
IL183983A0 (en) Processes for producing 4-aminoquinazoline derivatives
GB0418046D0 (en) Eantioselective process
GB0404793D0 (en) Process
GB0413053D0 (en) Process
GB0414847D0 (en) Process
GB0419075D0 (en) Process
IL178069A0 (en) Process for preparing n-aryl-piperazine derivatives
GB0410289D0 (en) Process
GB0406894D0 (en) Process
EP1754738A4 (en) Process for producing polypyridinium
GB0412875D0 (en) Process
GB0414335D0 (en) Process
EP1914313A4 (en) Method for producing cercosporamide
ZA200709013B (en) Method for producing 2-isopropenyl-5-methyl-4-hexen-1-yl 3-methyl-2-butenoate
IL183804A0 (en) Process for preparing substituted 2-alkoxycarbonyl-3-aminothiophenes
EP1976858A4 (en) Method for preparing 4-demethyldaunorubicin
GB0411583D0 (en) Process
GB0411185D0 (en) Process
EP1903047A4 (en) Method for producing trihydrocarbylborane
GB0413084D0 (en) Process
GB0413322D0 (en) Process

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees